Investigation of the effect of Dimethyl fumarate on T cells in patients with relapsing remitting Multiple Sclerosis
- Registry ID
- EUCTR2014-003481-25
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE4
- Sponsor
- Universitätsklinikum Münster
- Start date
- 2015-03-10
- Completion date
- 2018-05-07
- Last update
- 2026-08-16
Conditions
- relapsing remitting multiple sclerosis
Summary
This is an exploratory study design, which allows analysis of multiple immune parameters derived from peripheral blood mononuclear cells (PBMCs) from patients with relapsing remitting multiple sclerosis before and during immune-modulatory treatment with dimethyl fumarate (Tecfidera) in comparison to PBMCs from healthy subjects.
Locations
View on source registry